Cargando…
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural AL...
Autores principales: | Lou, Liang, Zhou, Shizhe, Tan, Sijia, Xiang, Menghua, Wang, Wei, Yuan, Chuang, Gao, Liqian, Xiao, Qicai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008889/ https://www.ncbi.nlm.nih.gov/pubmed/36923350 http://dx.doi.org/10.3389/fphar.2023.1137707 |
Ejemplares similares
-
Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
por: Wachowska, Małgorzata, et al.
Publicado: (2011) -
Editorial: Prodrug design and therapeutic applications
por: Xiao, Qicai, et al.
Publicado: (2023) -
Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy
por: Punjabi, Amol, et al.
Publicado: (2014) -
Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017) -
Potential Applications of Nanotechnology in Urological Cancer
por: He, Ming-Hui, et al.
Publicado: (2018)